Logo

Kinaxo Inks US, Japan Marketing Deals

Oct 15, 2008
NEW YORK (GenomeWeb News) – Martinsried, Germany-based Kinaxo Biotechnologies today said that it has inked sales and marketing pacts in the US and Japan for its Cellular Target Profiling service.
 
In the US, New York-based BioCatalyst International will support the introduction of the service, while UK-based BioFocus DPI will provide similar support in Japan.
 
Kinaxo’s CTP Service enables drug developers to determine the native cellular protein interactions of small molecule compounds in a physiological setting.
 
Further terms and details of the partnerships were not disclosed.

Breaking News
The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.